Ad Code: 31165

Hypertension and hypercholesterolemia are leading chronic disease risk factors that contribute to excess morbidity, mortality, and healthcare expenses in the US. Poor management of these conditions can increase risks for...

In a consensus document published in the European Heart Journal, recommendations are presented for the management of hypertension among children aged 6-16. On behalf of the ESC Council on Hypertension, European Association of...

The risk for major adverse cardiovascular events is reduced among patients within 6 months of previous MI who receive treatment with a polypill compared with usual care, according to a study published in NEJM. Jose M....

Several new non-statin agents have LDL cholesterol-lowering efficacy and can be considered for patients at risk for atherosclerotic cardiovascular disease (ASCVD), according to an expert consensus decision pathway published in...

Statin therapy appears to cause only a small excess risk for muscle symptoms, according to a study published in The Lancet. Christina Reith, MBChB, PhD, and colleagues examined adverse muscle events in large, long-term,...